Article

  • The EMBO Journal (1997) 16, 3987 - 3994
  • doi:10.1093/emboj/16.13.3987

Cells strongly expressing Igkappa transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers

Beatriz Goyenechea1,2, Norman Klix1,2, José Yélamos1, Gareth T. Williams1, Andrew Riddell1, Michael S. Neuberger1 and César Milstein1

  1. Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK
  2. B.Goyenechea and N.Klix contributed equally to this work

Correspondence to:

Michael S. NeubergerCésar Milstein,

Received 24 February 1997; Revised 26 March 1997


The V regions of immunoglobulin kappa transgenes are targets for hypermutation in germinal centre B cells. We show by use of modified transgenes that the recruitment of hypermutation is substantially impaired by deletion of the nuclear matrix attachment region (MAR) which flanks the intron-enhancer (Ei). Decreased mutation is also obtained if Ei, the core region of the kappa3'-enhancer (E3') or the E3'-flank are removed individually. A broad correlation between expression and mutation is indicated not only by the fact that the deletions affecting mutation also give reduced transgene expression, but especially by the finding that, within a single mouse, transgene mutation was considerably reduced in germinal centre B cells that poorly expressed the transgene as compared with strongly expressing cells. We also observed that the diminished mutation in transgenes carrying regulatory element deletions was manifested by an increased proportion of B cells in which the transgene had not been targeted at all for mutation rather than in the extent of mutation accumulation once targeted. Since mutations appear to be incorporated stepwise, the results point to a connection between transcription initiation and the clonal recruitment of hypermutation, with hypermutation being more fastidious than transcription in requiring the presence of a full complement of regulatory elements.

  • Keywords:

    • diversity,
    • enhancers,
    • hypermutation,
    • immunoglobulin,
    • MAR,
    • somatic mutation